MAM
FBRX icon

Meeder Asset Management’s Forte Biosciences FBRX Stock Holding History

Meeder Asset Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed -$4K – 2172
2020
Q1 		$4K Hold
8
– – ﹤0.01% 1860
2019
Q4 		$2K Buy
8
+7
+700% +$1.59K ﹤0.01% 2004
2019
Q3 		$0 Sell
1
-2
-67% -$3.04K ﹤0.01% 2174
2019
Q2 		$7K Sell
3
-14
-82% -$41.5K ﹤0.01% 1562
2019
Q1 		$69K Sell
17
-10
-37% -$38.6K 0.01% 791
2018
Q4 		$82K Buy
27
+17
+170% +$73.2K 0.01% 687
2018
Q3 		$59K Buy
+10
New +$38.1K ﹤0.01% 750

Other funds holding FBRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Meeder Asset Management's FBRX Position: Q2 2020 in Review

Meeder Asset Management sold out of Forte Biosciences (FBRX) in Q2 2020, closing a stake of 8 shares — an estimated $4K sold.

Meeder Asset Management first reported a position in FBRX in Q3 2018 and held it in 7 quarters. The position peaked at $82K in Q4 2018. 27 funds tracked by Wall St. Rank hold FBRX as of Q2 2020.

  • Meeder Asset Management reported no remaining Forte Biosciences position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 8 Forte Biosciences shares in Q2 2020, an estimated $4K.
  • Meeder Asset Management first reported a position in Forte Biosciences in Q3 2018 and held it in 7 quarters.
  • Meeder Asset Management's Forte Biosciences position peaked at $82K in Q4 2018.
  • 27 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.